2564 The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. (September 2015) - Van Soest, R.; Nieuweboer, A.; De Morrée, E.; Chitu, D.; Bergman, A.; Goey, H.; Bos, M.; Van der Meer, N.; Hamberg, P.; De Wit, R.; Mathijssen, R.